AI Training · Pharma & Life Sciences
AI Training for Pharma & Life Sciences
Scientific literature, medical content, regulatory documents, safety cases, SOPs, and field materials all depend on precise text. Pharma and life-sciences teams use this hands-on training to draft, summarize, and triage that material with generative AI.
Evidence checks, approved claims, and qualified human review stay built into every workflow, from the first draft to the final sign-off.
- modules
- 6
- hours
- 13

Some of the 500+ brands we've worked with
Selected brands we’ve worked with across industries.
Why this training
Why AI in this industry
The common assumption is that a language model reading a clinical paper is basically doing what a scientist does, just faster. It isn't. A model can summarize fluently and still invent a citation or drop a study limitation. It may also drift past an approved claim without any signal that something is wrong.
AI speeds up reading, structuring, and first drafts across the evidence chain — literature to briefs, regulatory drafts, safety intake to reporting — but never replaces scientific, medical, safety, or regulatory judgment. It never predicts molecular properties, runs bioinformatics, or produces a scientific conclusion; a scientist verifies every finding. In pharmacovigilance, AI only organizes or flags — a professional decides each case; in regulatory work, specialists alone own validation, approval, and submission. See the AI training catalog.
The reading queue never empties
Journal articles, congress materials, and evidence updates create a reading queue that never empties — AI can summarize and organize that material, but every scientific statement in the output still needs to be traced back to its source.
The same information gets rewritten into a new format constantly
Medical, regulatory, quality, and training teams turn one piece of approved information into a dozen different documents — AI-assisted drafting speeds up that first version while the document owner keeps control of review and approval.
One inconsistent term causes more rework than a slow draft
Medical responses, training material, SOP support, and field content all need the same terminology no matter which team wrote them — structured prompts and a controlled source pack make that consistency achievable without a slower process.
This data carries more risk than marketing copy
Safety narratives, research records, and health information can carry confidential or special-category data without anyone noticing at first glance — teams need a plain rule for what's allowed into which tool before anyone experiments.
Verification is the skill
A fluent answer can misstate a study or invent a citation and read exactly as confidently either way — organizations that get value teach people to check sources and escalate uncertainty instead of trusting output at face value.
Syllabus
Training syllabus
Generative AI foundations for pharma and life sciences
120 minBeginner
What large language models do well, where they quietly fail, and why scientific, medical, regulatory, and safety work needs tighter controls than most industries. Teams build a common vocabulary here and learn to tell drafting support apart from an actual clinical or regulatory decision.
- What a language model is doing when it drafts an answer
- Citation errors and hallucinations behind unsupported claims
- Task lines: where drafting support ends and an expert decision begins
- Where AI already shows up in the office tools everyone already has
- A first experiment worth trying because the risk is genuinely low
- A model for reviewing and escalating anything higher-stakes
Prompt craft grounded in sources and validation
120 minBeginner
A repeatable structure for life-sciences documents keeps every draft traceable to its basis, with purpose, audience, approved sources, task, format, and checks all made explicit before participants verify each material statement and move it forward.
- A prompt template built for scientific and operational documents
- Supplying approved context without exposing anything confidential
- A source-linked summary, always
- Checking a quotation, reference, figure, or study detail against its source
- Telling a source fact apart from a model suggestion and a reviewer's conclusion
- Building a controlled prompt and source library as a team
Scientific literature and medical affairs content
150 minIntermediate
Literature monitoring and scientific summarization support medical affairs content workflows under one rule: everything stays traceable. AI screens, structures, and drafts, while a qualified reviewer still decides relevance, scientific accuracy, balance, and whether something is fit to use.
- Summarizing a publication with every claim linked to its source passage
- Literature monitoring with relevance tags and a working review queue
- Evidence tables, briefing notes
- A first draft of medical information or educational content
- Reshaping one approved evidence base for several professional audiences
- Scientific review for missing context or overstatement, including invented citations
Regulatory, quality, SOP, and training documents
150 minIntermediate
Regulatory affairs, quality, and learning all produce document-heavy work: structured first drafts, controlled rewrites, comparisons, and consistency checks. AI supports the document preparation here, while accountable specialists keep authorship, validation, approval, and submission decisions.
- Drafting a regulatory-document section from approved structured input
- Comparing versions and flagging what's missing or inconsistent
- Turning an approved procedure into SOP support and training material
- Learning aids and FAQs
- Keeping defined terminology the same across an entire document set
- Ownership, validation, approval, and an audit trail for every review gate
Pharmacovigilance support within responsible data boundaries
120 minIntermediate
Clear boundaries for confidential, personal, health, and special-category data sit alongside a careful pharmacovigilance use case here. Participants learn where AI can help organize or prioritize information. A qualified safety professional still reviews and assesses every case before deciding it.
- Naming confidential, personal, health, and special-category data correctly
- What separates a consumer tool from an enterprise one, prompt by prompt
- De-identification and minimization through synthetic examples in exercises
- Pharmacovigilance intake and triage support that stops short of a case decision
- Qualified human review with escalation and a documented rationale
- Logging AI-assisted work and flagging uncertain output
Approved commercial content and governed rollout
120 minAdvanced
Commercial and field-team content gets created here inside approved claims, followed by a practical adoption plan. Teams design controlled pilots, review paths, reusable assets, and measurement that rewards reliable use over raw output volume.
- Drafting field and commercial content from an approved claim library
- Adjusting tone and format without expanding or changing the claim
- Medical, legal, regulatory checkpoints
- Choosing a pilot workflow by value and sensitivity against review effort
- A champions model spanning medical, regulatory, safety, quality, and commercial teams
- A 90-day rollout plan with named owners and a feedback loop
Outcomes
Outcomes & audience
What you will learn
- Summarize scientific text, source-linked, then verify against the original
- A literature flow, reviewer-ready
- Draft medical, regulatory, SOP, or training content from approved inputs
- Create commercial and field-team drafts that never leave the approved claim or its review path
- Use AI for pharmacovigilance intake and triage support, while safety assessment and case decisions stay with a qualified person
- Handle confidential, personal, health, or special-category data inside clear boundaries
- Catch errors before they ship
- Plan a governed path from pilot to rollout, with named owners, review gates, and reusable prompt assets
Who should attend
- Medical affairs and medical information teams
- Regulatory affairs and submissions teams
- Pharmacovigilance and drug-safety teams
- Quality and learning teams responsible for SOPs
- Commercial excellence and marketing teams supporting the field force
- Digital, data, legal, compliance, and transformation leaders
Format
Training format
Life-sciences functions share two days, usually split into half-day sessions so scientific, safety, regulatory, and commercial reviewers can each join the workshops most relevant to them. Onsite and live-online formats cover the same syllabus.
- Format
- Onsite or live online
- Duration
- 2 days (about 13 hours, can be split into half-day sessions)
- Group size
- Up to 20 participants per group
- Language
- English or Turkish
- Materials
- Prompt library, validation checklists, document templates, and exercise workbook
- Certificate
- Certificate of completion
Keep exploring
Related programs




Next step
Let's shape this around your functions

Questions
Frequently asked questions
Which functions actually sit in this training?
Medical affairs, regulatory affairs, pharmacovigilance, quality, learning, commercial, digital, legal, and compliance teams across pharma, biotech, and life-sciences organizations. Cohorts group by function, so each team spends its time on the document types and review boundaries that are theirs.
Is a data-science or technical background required?
Coding or machine-learning experience is not assumed. What matters more is familiarity with the documents, evidence, review steps, or communication workflows a participant already owns.
How are the sessions arranged?
About 13 hours across two days, run onsite or live online, splitting easily into half-day blocks with specific deep dives available to just the functions that need them.
Does the syllabus actually reflect our products and document lifecycle?
Before the training we map your functions, document types, tool boundaries, and review paths. The exercise material is then built to that shape and fabricated outright, so we never need your real product claims, confidential information, or identifiable safety and health data to make it realistic.
Does completing this training certify anything regulatory or compliance-related?
No. This is skills training, not a regulatory assessment, legal or medical advice, or a compliance certification. It builds safer drafting, checking, and escalation habits, and your accountable medical, safety, regulatory, quality, legal, and compliance functions keep every one of their existing responsibilities.
Does any of this let AI make a clinical, regulatory or pharmacovigilance decision?
No. This training does not teach anyone to hand case assessment, signal evaluation, clinical judgement, regulatory strategy, approval, or submission decisions to a model. AI can support intake, organization, summarization, drafting, and triage work, but a qualified person still reviews the evidence and makes the call.
Which specific tools do people practice on?
The core skills transfer across mainstream and organization-approved enterprise tools alike. If your organization already runs a validated or controlled internal environment, exercises can move onto its permitted capabilities and data rules, though the training itself does not validate any tool.
Does any confidential, patient, trial, or safety-case data enter the room?
None. The material is fabricated or fully anonymized, so nothing confidential, patient-identifying, or trial-specific has to travel. One module covers special-category data, tool approval, minimization, and escalation. Patient-facing clinical workflows sit outside this program and are covered in our AI training for healthcare. Here the focus stays on organizational document lifecycles and life-sciences functions.